Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
IL-27 plasma level in relapsing remitting multiple sclerosis subjects: The double-faced cytokine.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in the province of Alicante].
Management of Spinal Deformity in Adult Patients With Neuromuscular Disease.
Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
Design of a strong cation exchange methodology for the evaluation of charge heterogeneity in glatiramer acetate.
Neurologic syndrome associated with homozygous mutation at MAG sialic acid binding site.
Identification of Ser-Pro-Cys-Peptide in Blood Serum of Multiple Sclerosis Patients.
Multiple sclerosis: Single mutation associated with familial progressive MS.
Thrombomodulin dependent protein C activation is required for mitochondrial function and myelination in the CNS.
Whole Exome Sequencing Identifies the Genetic Basis of Late-Onset Leigh Syndrome in a Patient with MRI but Little Biochemical Evidence of a Mitochondrial Disorder.
Voluntary Running Triggers VGF-Mediated Oligodendrogenesis to Prolong the Lifespan of Snf2h-Null Ataxic Mice.
Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens.
Lesson of the month 1: Post-malaria neurological syndromes.
Contribution of iron and protein contents from rat brain subcellular fractions to MR phase imaging.
Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.
Limbic Pathway Correlates of Cognitive Impairment in Multiple Sclerosis.
Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.
Cuprizone demyelination induces a unique inflammatory response in the subventricular zone.
Comment on Paraparetic Guillain-Barré syndrome: non-demyelinating reversible conduction failure restricted to the lower limbs.
[Clinical and demographic characteristics of patients with multiple sclerosis].
Correlation between antibodies to bisphenol A, its target enzyme protein disulfide isomerase and antibodies to neuron-specific antigens.
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself.
Heterogeneous anisotropic magnetic susceptibility of the myelin-water layers causes local magnetic field perturbations in axons.
Ongoing increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 50-year study.
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.